is zepbound like mounjaro

Zacks Investment Research on MSN: How will Mounjaro and Zepbound sales aid LLY's upcoming Q1 results? Eli Lilly LLY has emerged as a dominant force in the cardiometabolic market, driven by strong demand for its blockbuster GLP-1 therapies, Mounjaro for type II diabetes (T2D) and Zepbound for obesity. CNBC: Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar Eli Lilly posted fourth-quarter earnings and revenue and 2026 guidance that blew past estimates, as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soars.

Understanding the Context

The ... Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar MarketWatch: Lilly says Mounjaro and Zepbound sales more than doubled, as stock rallies Eli Lilly’s stock closed 10.3% higher on Wednesday after the drug giant reported triple-digit growth of Zepbound and Mounjaro, its game-changing weight-loss and Type 2 diabetes drugs. That’s the third ... Lilly says Mounjaro and Zepbound sales more than doubled, as stock rallies CLEVELAND, Ohio — More people are taking GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight and control Type 2 diabetes.